Latest news about Hannah Joseph Hospital
Hannah Joseph Hospital
100.00
-1.80(-1.77%)
Company Performance:
View Company Insights1D-1.77%
1M-13.42%
6M+47.82%
1Y+46.52%
5Y+46.52%
More news about Hannah Joseph Hospital
29May 26
Hannah Joseph Hospital FY26 net profit rises 55% to ₹1,118.12 lakh
Hannah Joseph Hospital reported a 55.1% increase in net profit to ₹1,118.12 lakh for FY26, driven by an 18.7% rise in revenue to ₹9,205.17 lakh. The Board approved a final dividend of ₹2 per share and re-appointed M/s. Pandiarajan.T & Co. as Internal Auditors. The company confirmed no deviation in the utilization of its ₹4,200 lakh IPO proceeds.
21May 26
Hannah Joseph Hospital board meets May 29 to consider FY26 results, dividend
Hannah Joseph Hospital Limited has issued a revised intimation for its board meeting scheduled on May 29, 2026, to approve audited financial results for the half year and financial year ended March 31, 2026. The board will also consider recommending a final dividend on equity shares for FY26. The trading window for insiders remains closed from April 1, 2026, until 48 hours after the results declaration.
09Apr 26
Hannah Joseph Hospital Limited Submits SEBI Compliance Certificate for Q4FY26
Hannah Joseph Hospital Limited submitted its quarterly compliance certificate pursuant to SEBI Regulation 74(5) for Q4FY26 ended March 31, 2026. The certificate, issued by registrar BTS Consultancy Services Private Limited, confirms that the regulation is not applicable as all equity shares are held in demat form. The filing was completed on April 09, 2026, as part of the company's regular compliance obligations with BSE Limited.
06Apr 26
Hannah Joseph Hospital Limited Reports Insider Share Acquisition of 26,000 Equity Shares by Senior Management Personnel
Hannah Joseph Hospital Limited disclosed that Dr. Natarajan Arunkumar, senior management personnel, acquired 26,000 equity shares worth Rs. 16,19,420 through three on-market transactions on BSE between February and March 2026. His shareholding increased from 60,060 shares (0.26%) to 86,060 shares (0.38%). The company reported this insider trading activity to BSE on April 06, 2026, in compliance with SEBI regulations.
03Apr 26
Hannah Joseph Hospital Files Annual Encumbrance Declaration for FY26 Under SEBI Rules
Hannah Joseph Hospital Limited completed its annual regulatory filing under SEBI SAST Regulation 31(4) for FY26, with promoter Dr. Mosesjoseph Arunkumar declaring no encumbrance on promoter group shares. The filing follows earlier share acquisition activity where the promoter increased his stake to 69.41% through open market purchases.
20Mar 26
Hannah Joseph Hospital Promoter Dr. Moses Joseph Arunkumar Increases Stake to 67.51%
Hannah Joseph Hospital Limited's promoter Dr. Moses Joseph Arunkumar has increased his shareholding to 67.51% through the acquisition of 1,62,000 equity shares valued at Rs. 1,00,06,465. The open market transaction was completed on March 19, 2026, and disclosed under SEBI SAST regulations, with detailed information about persons acting in concert also provided in the regulatory filing.
Industry PeersHannah Joseph Hospital
100.00
(-1.77%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
